Firm will couple SeqCapEZ Exome with next-gen sequencing for genomic enrichment.

Ambry Genetics has become the first Certified Service Provider (CSP) in the U.S. for NimbleGen’s SeqCap EZ Exome sequence-capture technology. Status as a CSP means Ambry will be able to offer target-enrichment services using the SeqCap EZ Human Exome coupled with next-gen sequencing services for genetic research.
The workflow will involve processing customer gDNA samples for genomic enrichment using 2.1 million optimized DNA probes from SeqCap EZ Exome, in order to capture all human coding exons, followed by sequencing using short-read, paired-end technology.

Previous articleSantarus Licenses Approved Antidiabetic from S2 Therapeutics and VeroScience
Next articleBTG and Ortho Biotech’s Prostate Cancer Trial Unblinded